SAN DIEGO, Oct. 21 /PRNewswire/ -- Althea Technologies, Inc., a leading provider of innovative services and technologies for pharmaceutical development and manufacturing, announced today that Shabbir Anik, Ph.D., will join the company as its President and Chief Executive Officer. Dr. Anik, the former President of Pharmaceutical Development Services (PDS) at Patheon, Inc., will lead Althea's expansion of its product development, clinical trial and commercial manufacturing services.
"We are delighted to welcome Dr. Anik to Althea and feel that his background and expertise is a wonderful match for the company," stated Dr. Magda Marquet, Co-Chair of Althea Technologies. "He is a rare blend of scientist, manager and leader, and we are excited about Althea's continued success with Shabbir at the helm. Althea has emerged as a leader in speeding biopharmaceuticals and exciting new therapeutics to clinical evaluation. That position has been recently enhanced with our addition of commercial manufacturing services. As we continue to grow to serve our clients, Shabbir's experience in manufacturing, his understanding of the critical interplay of services in bringing a product to commercial success, and his ability to manage these activities across the globe will be invaluable to Althea."
Dr. Anik holds a Ph.D. in Pharmaceutical Sciences from the University of Wisconsin and an MBA from Santa Clara University. He began his career at Syntex, serving in positions of increasing responsibility leading to the position of Vice President and Program Director. He also served as Senior Director of Pharmaceutical Development and Operations for the biotechnology company Neurex, before most recently joining Patheon, Inc., where he was responsible for building and managing Patheon's global PDS business.
|SOURCE Althea Technologies, Inc.|
Copyright©2008 PR Newswire.
All rights reserved